Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Activist Investor Starboard Value Takes $1B Stake in Pfizer
Pfizer’s bondholders cheer news of activist investor Starboard’s $1 billion investment
Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug company. Bondholders seem to like the news too.
Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help
Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its COVID-19 products.
Activist investor Starboard Value takes $1 bln stake in Pfizer, sources say
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make changes to turn its performance around, sources familiar with the matter said on Sunday.
Pfizer, Arcadium Lithium, Richemont
Why Pfizer Stock Popped on Monday
How Pfizer got itself in a pickle. As the Journal explains, Pfizer bet big on vaccines to protect people from COVID, but as the pandemic waned, so did interest in (and sales of) i
Stocks to Watch Monday: Pfizer, Arcadium Lithium, Richemont
Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the struggling drugmaker to make changes to turn its performance around, [The Wall Street Journal reported](
These Stocks Are Moving the Most Today: Pfizer, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, Duckhorn, and More
Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Apple and Amazon shares are downgraded, and Rio Tinto approaches Arcadium Lithium about a potential acquisition.
12h
Pfizer goes from hunter to hunted as Starboard circles
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
45m
Why Pfizer will find it hard to appease its activist investor
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
17h
Meet Jeff Smith, the hedge-fund investor taking on Pfizer
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
North Dakota wildfires
Kemp suspends GA mayor
Milton becomes Category 5
Medical copter crash kills 3
Sex abuse case dismissed
Human life expectancy study
Harris on '60 Minutes'
Tickets to climb to $5
Ranger dies during rescue
Vanderbilt, Arkansas fined
Richest female musician
NC voting rule changes
King named grand marshal
US overdose deaths drop
Ordered to open app store
Grammy-winning singer dies
Intel defensive briefings rise
States sue TikTok
To replace lead water pipes
Win Nobel Prize in physics
SCOTUS denies appeal
Liquidation plan approved
Hera mission launched
Former aide charged
Athlete payments approval
Targeted by a cyberattack
Israel expands offensive
Hamas backers sanctioned
Settles latest civil lawsuit
Related topics
Ian Read
Pharma
Feedback